ETF comparison
Verified factor-similar pair

AVUV vs CSB

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB HML RMW
Similarity score
84
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • CSB has the higher backtested relative Sharpe (1.125 vs 1.114).
  • AVUV has the lower published fee (0.25% vs 0.40%).
  • AVUV is cheaper on dividend valuation (132 vs 134, where 100 is each fund's historical median).
  • AVUV has the stronger regression fit (adjusted R-squared 0.976 vs 0.949).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

AVUV

Avantis U.S. Small Cap Value ETF
SMB HML RMW
Adj. R2
0.976
Rel. Sharpe
1.114
Mkt beta
1.06
AUM
US$24.8B
MER
0.25%
Valuation
132

CSB

VictoryShares US Small Cap High Dividend Volatility Wtd ETF
SMB HML RMW
Adj. R2
0.949
Rel. Sharpe
1.125
Mkt beta
0.81
AUM
US$261M
MER
0.40%
Valuation
134

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
AVUV
+0.90
|t|
+16.5
CSB
+0.81
|t|
+16.8
diff +0.09
HML
AVUV
+0.53
|t|
+11.7
CSB
+0.35
|t|
+8.3
diff +0.18
RMW
AVUV
+0.27
|t|
+5.0
CSB
+0.35
|t|
+6.7
diff -0.08
CMA
AVUV
-0.04
|t|
-0.7
CSB
+0.04
|t|
+0.7
diff -0.08
UMD
AVUV
-0.01
|t|
-0.3
CSB
-0.05
|t|
-1.5
diff +0.04

Why This Pair Matches

Exposure level
83
Exposure shape
99
Mkt beta diff
0.25
Rel. Sharpe diff
0.012

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

AVUV fund page CSB fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.